These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24503555)

  • 1. Molecular imaging of Alzheimer disease pathology.
    Kantarci K
    AJNR Am J Neuroradiol; 2014 Jun; 35(6 Suppl):S12-7. PubMed ID: 24503555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET imaging of brain amyloid in dementia: a review.
    Quigley H; Colloby SJ; O'Brien JT
    Int J Geriatr Psychiatry; 2011 Oct; 26(10):991-9. PubMed ID: 21905095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid imaging of Lewy body-associated disorders.
    Foster ER; Campbell MC; Burack MA; Hartlein J; Flores HP; Cairns NJ; Hershey T; Perlmutter JS
    Mov Disord; 2010 Nov; 25(15):2516-23. PubMed ID: 20922808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Plasma Neurofilament Light in the 1Florida Alzheimer's Disease Research Center (ADRC).
    Barker W; Quinonez C; Greig MT; Behar R; Chirinos C; Rodriguez RA; Rosselli M; Rodriguez MJ; Cid RC; Rundek T; McFarland K; Hanson K; Smith G; DeKosky S; Vaillancourt D; Adjouadi M; Marsiske M; Ertekin-Taner N; Golde T; Loewenstein DA; Duara R
    J Alzheimers Dis; 2021; 79(1):59-70. PubMed ID: 33216030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies.
    Donaghy PC; Firbank MJ; Thomas AJ; Lloyd J; Petrides G; Barnett N; Olsen K; O'Brien JT
    Mov Disord; 2018 Jul; 33(7):1130-1138. PubMed ID: 29672930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal PET Imaging of Amyloid and Tau Pathology in Alzheimer Disease and Non-Alzheimer Disease Dementias.
    Xia C; Dickerson BC
    PET Clin; 2017 Jul; 12(3):351-359. PubMed ID: 28576172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid PET Imaging in Lewy body disorders.
    Donaghy P; Thomas AJ; O'Brien JT
    Am J Geriatr Psychiatry; 2015 Jan; 23(1):23-37. PubMed ID: 23831180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis of neurodegenerative dementias using metabolic phenotypes on F-18 FDG PET/CT.
    Tripathi M; Tripathi M; Damle N; Kushwaha S; Jaimini A; D'Souza MM; Sharma R; Saw S; Mondal A
    Neuroradiol J; 2014 Feb; 27(1):13-21. PubMed ID: 24571830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular neuroimaging in Alzheimer's disease.
    Matsuda H; Imabayashi E
    Neuroimaging Clin N Am; 2012 Feb; 22(1):57-65, viii. PubMed ID: 22284733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid Imaging and Longitudinal Clinical Progression in Dementia With Lewy Bodies.
    Donaghy PC; Firbank MJ; Thomas AJ; Lloyd J; Petrides G; Barnett N; Olsen K; O'Brien JT
    Am J Geriatr Psychiatry; 2020 May; 28(5):573-577. PubMed ID: 31953009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between amyloid-beta deposition and cortical thickness in dementia with Lewy bodies.
    Chin KS; Gajamange S; Desmond PM; Villemagne VL; Rowe CC; Churilov L; Yassi N; Watson R
    Aust N Z J Psychiatry; 2023 Apr; 57(4):594-602. PubMed ID: 35196886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy.
    Padovani A; Benussi A; Cotelli MS; Ferrari C; Cantoni V; Dell'Era V; Turrone R; Paghera B; Borroni B
    Alzheimers Res Ther; 2019 Dec; 11(1):95. PubMed ID: 31787103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging of Diseases Causing Dementia.
    Masdeu JC
    Neurol Clin; 2020 Feb; 38(1):65-94. PubMed ID: 31761062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic imaging: clinical utility now and in the future.
    Walker Z; Rodda J
    Int Psychogeriatr; 2011 Sep; 23 Suppl 2():S32-40. PubMed ID: 21843378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
    Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
    J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.
    Thal DR; Ronisz A; Tousseyn T; Rijal Upadhaya A; Balakrishnan K; Vandenberghe R; Vandenbulcke M; von Arnim CAF; Otto M; Beach TG; Lilja J; Heurling K; Chakrabarty A; Ismail A; Buckley C; Smith APL; Kumar S; Farrar G; Walter J
    Acta Neuropathol Commun; 2019 Nov; 7(1):178. PubMed ID: 31727169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease.
    Shirvan J; Clement N; Ye R; Katz S; Schultz A; Johnson KA; Gomez-Isla T; Frosch M; Growdon JH; Gomperts SN
    Neurology; 2019 Jul; 93(5):e476-e484. PubMed ID: 31243072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta.
    Cohen AD; Rabinovici GD; Mathis CA; Jagust WJ; Klunk WE; Ikonomovic MD
    Adv Pharmacol; 2012; 64():27-81. PubMed ID: 22840744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain PET in the diagnosis of Alzheimer's disease.
    Marcus C; Mena E; Subramaniam RM
    Clin Nucl Med; 2014 Oct; 39(10):e413-22; quiz e423-6. PubMed ID: 25199063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.